COVID-19 and Long COVID: Disruption of the Neurovascular Unit, Blood-Brain Barrier, and Tight Junctions

COVID-19 и длительный COVID: нарушение нейроваскулярной единицы, гематоэнцефалического барьера и плотных контактов
Theoharis Constantin Theoharides, Lubov Nathanson, Duraisamy Kempuraj, Nancy G. Klimas, Jessica R. Cohen, Kristina K. Aenlle, Annette Mathew, Dylan Isler, Rajendra P. Pangeni, Jessica Cohen
2023-09-11

SARS-CoV-2blood-brain barrierlong COVIDneurovascular unittight junction proteins
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), could affect brain structure and function. SARS-CoV-2 can enter the brain through different routes, including the olfactory, trigeminal, and vagus nerves, and through blood and immunocytes. SARS-CoV-2 may also enter the brain from the peripheral blood through a disrupted blood-brain barrier (BBB). The neurovascular unit in the brain, composed of neurons, astrocytes, endothelial cells, and pericytes, protects brain parenchyma by regulating the entry of substances from the blood. The endothelial cells, pericytes, and astrocytes highly express angiotensin converting enzyme 2 (ACE2), indicating that the BBB can be disturbed by SARS-CoV-2 and lead to derangements of tight junction and adherens junction proteins. This leads to increased BBB permeability, leakage of blood components, and movement of immune cells into the brain parenchyma. SARS-CoV-2 may also cross microvascular endothelial cells through an ACE2 receptor-associated pathway. The exact mechanism of BBB dysregulation in COVID-19/neuro-COVID is not clearly known, nor is the development of long COVID. Various blood biomarkers could indicate disease severity and neurologic complications in COVID-19 and help objectively diagnose those developing long COVID. This review highlights the importance of neurovascular and BBB disruption, as well as some potentially useful biomarkers in COVID-19, and long COVID/neuro-COVID.
1
ACE2 expression in endothelial cells, pericytes, and astrocytes suggests that SARS-CoV-2 can directly affect neurovascular-unit components.
2
Increased BBB permeability may facilitate immune-cell migration into the brain parenchyma and contribute to neurological complications of COVID-19.
3
Neurovascular-unit disruption may alter tight and adherens junction proteins, increasing BBB permeability and causing leakage of blood components into brain tissue.
4
SARS-CoV-2 may cross brain microvascular endothelial cells through an ACE2 receptor-associated pathway.
5
SARS-CoV-2 may reach the brain through olfactory, trigeminal, and vagus nerves, as well as blood, immunocytes, and a disrupted blood-brain barrier.
6
The mechanisms underlying BBB dysregulation and long COVID remain unclear, while blood biomarkers may help assess severity and identify neurological complications or long COVID.

The brain neurovascular unit and blood-brain barrier in COVID-19 and long COVID/neuro-COVID

SARS-CoV-2-associated disruption of neurovascular and blood-brain barrier integrity, including tight-junction derangement, increased permeability, leakage, immune-cell entry, and related biomarkers

Publication Details
Publication Date
2023-09-11
Journal
Publisher
ISSN
Cited by
60
Access Type
Author Information
Authors
Theoharis Constantin Theoharides
Lubov Nathanson
Duraisamy Kempuraj
Nancy G. Klimas
Jessica R. Cohen
Kristina K. Aenlle
Annette Mathew
Dylan Isler
Rajendra P. Pangeni
Jessica Cohen
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%